StonvexLoading…
StonvexStonvexStonvexCore line items from SIBN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $52.59M | $200.93M | $144.58M | $95.92M |
Operating Income | $-5.09M | $-22.33M | $-19.87M | $-14.48M |
Net Income | $-4.33M | $-18.90M | $-17.26M | $-6.15M |
EPS (Diluted) | $-0.10 | $-0.44 | $-0.40 | $-0.30 |
Total Assets | $242.72M | $238.56M | $234.27M | $230.92M |
Total Liabilities | $63.78M | $61.02M | $62.15M | $60.58M |
Cash & Equivalents | $33.53M | $42.24M | $26.49M | $34.15M |
Free Cash Flow OCF − CapEx | $-3.44M | $-9.09M | $-9.53M | $-8.91M |
Shares Outstanding | 44.20M | 43.65M | 43.27M | 43.01M |